These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20370446

  • 21. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 23. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
    Sommerer C, Giese T, Schmidt J, Meuer S, Zeier M.
    Transplantation; 2008 Jan 15; 85(1):15-21. PubMed ID: 18192906
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 25. Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
    Ray JE, Keogh AM, McLachlan AJ.
    J Heart Lung Transplant; 2006 Oct 15; 25(10):1223-9. PubMed ID: 17045935
    [Abstract] [Full Text] [Related]

  • 26. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov 15; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 27. Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients.
    Langer RM, Kahan BD.
    Transplantation; 2003 Jul 27; 76(2):318-23. PubMed ID: 12883185
    [Abstract] [Full Text] [Related]

  • 28. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
    Hazzan M, Buob D, Labalette M, Provot F, Glowacki F, Hoffmann M, Copin MC, Noel C.
    Transplantation; 2006 Sep 15; 82(5):657-62. PubMed ID: 16969289
    [Abstract] [Full Text] [Related]

  • 29. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H, Wagner C, Korn A, Christians U.
    Med Klin (Munich); 1997 Oct 15; 92(10):589-96. PubMed ID: 9446006
    [Abstract] [Full Text] [Related]

  • 30. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A, Bruzzi I, Mister M, Azzollini N, Gaspari F, Perico N, Gotti E, Bertani T, Remuzzi G.
    Kidney Int; 1999 Feb 15; 55(2):674-85. PubMed ID: 9987092
    [Abstract] [Full Text] [Related]

  • 31. Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allografts.
    Bigaud M, Wieczorek G, Beerli C, Audet M, Blancher A, Heusser C, Morris RE, Wagner J.
    Transplantation; 2012 Jan 27; 93(2):156-64. PubMed ID: 22179400
    [Abstract] [Full Text] [Related]

  • 32. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
    Kasiske BL, Johnson HJ, Goerdt PJ, Heim-Duthoy KL, Rao VK, Dahl DC, Ney AL, Andersen RC, Jacobs DM, Odland MD.
    Am J Kidney Dis; 1997 Nov 27; 30(5):639-45. PubMed ID: 9370178
    [Abstract] [Full Text] [Related]

  • 33. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
    Wang Y, Wang C, Li J, Wang X, Zhu G, Chen X, Bi H, Huang M.
    Eur J Clin Pharmacol; 2009 Mar 27; 65(3):239-47. PubMed ID: 18936931
    [Abstract] [Full Text] [Related]

  • 34. Diltiazem in renal allograft recipients receiving cyclosporine.
    Chrysostomou A, Walker RG, Russ GR, d'Apice AJ, Kincaid-Smith P, Mathew TH.
    Transplantation; 1993 Feb 27; 55(2):300-4. PubMed ID: 8434380
    [Abstract] [Full Text] [Related]

  • 35. Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.
    Ray JE, Keogh AM, McLachlan AJ, Akhlaghi F.
    J Heart Lung Transplant; 2003 Jul 27; 22(7):715-22. PubMed ID: 12873538
    [Abstract] [Full Text] [Related]

  • 36. Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients.
    Alberú J, Gatica M, Cachafeiro-Vilar M, Robles-Díaz G, Bezaury P, Paz-Pinedo F, Vargas-Vorácková F.
    Rev Invest Clin; 2001 Jul 27; 53(5):396-400. PubMed ID: 11795104
    [Abstract] [Full Text] [Related]

  • 37. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study.
    Ladefoged SD, Pedersen E, Hammer M, Rasmussen KC, Hansen FM, Andersen CB.
    Nephrol Dial Transplant; 1994 Jul 27; 9(5):543-7. PubMed ID: 8090335
    [Abstract] [Full Text] [Related]

  • 38. Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
    Shalaby U.
    Jpn J Ophthalmol; 2017 Mar 27; 61(2):169-178. PubMed ID: 27943089
    [Abstract] [Full Text] [Related]

  • 39. Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin.
    Kumana CR, Tong MK, Li CS, Lauder IJ, Lee JS, Kou M, Walley T, Haycox A, Chan TM.
    Br J Clin Pharmacol; 2003 Dec 27; 56(6):670-8. PubMed ID: 14616428
    [Abstract] [Full Text] [Related]

  • 40. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome.
    Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL, Karlix JL.
    Transplantation; 1994 Mar 27; 57(6):889-92. PubMed ID: 8154037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.